Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
ORTINGLOBE
₹16.50
₹15.92
₹17.13
₹10.66
₹21.30
Markets Today
Historical Performance
As of 10-07-2026 23:15, Ortin Global Ltd. share price today is ₹0, with a change of ₹-16.32 (-100.00%) from the previous close of ₹16.32. The stock opened at ₹17 and traded between ₹15.92 and ₹17.13, with a total traded volume of 67770 shares. The company has a market capitalization of ₹13.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹21.3 and ₹10.66, respectively.
Ortin Global Ltd. valuation metrics include a P/E ratio of -17.9, and book value of ₹10.70. Profitability indicators show ROE of -59.84%. Ortin Global Ltd. has reported revenue of ₹0.1 Cr and net profit of ₹-0.74 Cr.
Ortin Global Ltd. technical indicators include Day RSI at 45.88, Day MFI at 41.72, Day ADX at 16.14. Additional indicators include Commodity Channel Index (CCI) at -145.6 and Williams %R at -76.83. Momentum indicators show Day MACD at 0.05, Day MACD Signal Line at 0.21, DayATR at 1.16. Rate of Change indicators for Ortin Global Ltd. include ROC125 at 15.34 and ROC21 at -8.98.
Exponential moving averages include EMA5 at ₹16.6, EMA10 at ₹16.8, EMA12 at ₹16.8, EMA20 at ₹16.8, EMA26 at ₹16.8, EMA50 at ₹16.4, EMA100 at ₹15.8, EMA200 at ₹15. Simple moving averages include SMA5 at ₹16.6, SMA10 at ₹16.9, SMA20 at ₹17, SMA30 at ₹17, SMA50 at ₹16.2, SMA100 at ₹16, SMA150 at ₹15.1, SMA200 at ₹14.3.
Support levels for Ortin Global are placed at First Support ₹15.67, Second Support ₹15.01, Third Support ₹14.31. Resistance levels are seen at First Resistance ₹17.03, Second Resistance ₹17.73, Third Resistance ₹18.39. Ortin Global Ltd. shareholding pattern shows promoter holding at 1.23%, FII holding at 1.68%, DII holding at 0%, public holding at 97.1%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 0.03 | 0.01 | 0.01 | 0.04 | 0.09 |
| Operating Expense | 0.32 | 0.06 | 0.52 | 0.24 | 0.25 |
| Operating Profit | -0.28 | -0.05 | -0.50 | -0.20 | -0.16 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0.01 | 0 |
| Net Profit | -0.01 | -0.05 | -0.50 | -0.18 | -0.16 |
₹16.50
↗ Bullish Moving Average
6
↘ Bearish Moving Average
10
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| FII | 6.2 | 6.5 | 6.5 | 1.7 | 1.7 | 1.7 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 92.5 | 92.2 | 92.2 | 97.1 | 97.1 | 97.1 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 10.8 K | 10.8 K | 100.00% |
| Week | 26.03 K | 26.03 K | 100.00% |
| 1 Month | 18.48 K | 19.39 K | 95.33% |
| 6 Month | 19.8 K | 20.69 K | 95.69% |
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 24 Sep, 2013 | 0.25 | FINAL | Equity Share | |
| 24 Sep, 2012 | 0.5 | FINAL | Equity Share | |
| 13 Oct, 2011 | 0.5 | FINAL | 15 Oct, 2011 | Equity Share |
| 23 Sep, 2010 | 0.8 | FINAL | Equity Share | |
| 23 Sep, 2009 | 0.8 | FINAL | Equity Share | |
| 24 Sep, 2008 | 0.8 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹587.60 | ₹5.40 | ₹179.17 | ₹15.60 | ₹535 | ₹62 |
| % Change | -1.43% | -0.18% | -2.00% | 0.84% | -0.10% | -0.26% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹237.47 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹-3.28 |
| PE TTM | - | -1.30 | 47.70 | 29.60 | 26.70 | -103.00 |
| 1 Year Return | 52.07 | 441 | 45.1 | 70 | -25.38 | -41.91 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Dishman Carbogen Amcis Ltd.
₹ 195.49
+1.38%
Lasa Supergenerics Ltd.
₹ 7.52
+1.21%
Advanced Enzyme Technologies Ltd.
₹ 330.00
+1.74%
Bajaj Healthcare Ltd.
₹ 345.50
-1.31%
Brooks Laboratories Ltd.
₹ 69.90
-0.87%
RPG Life Sciences Ltd.
₹ 2861.10
+7.69%
Bafna Pharmaceuticals Ltd.
₹ 204.61
+2.00%
Alpa Laboratories Ltd.
₹ 68.70
+0.60%
SMS Pharmaceuticals Ltd.
₹ 403.00
-0.99%
Nectar Lifesciences Ltd.
₹ 11.21
-0.18%
Mangalam Drugs and Organics Ltd.
₹ 27.75
+1.80%
Indoco Remedies Ltd.
₹ 259.00
+1.53%
Ind-Swift Laboratories Ltd.
₹ 247.05
+4.87%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
+0.01%
Panacea Biotec Ltd.
₹ 546.00
-1.66%
Medicamen Biotech Ltd.
₹ 244.00
-0.57%
Themis Medicare Ltd.
₹ 117.59
+1.33%
By signing up I certify terms, conditions & privacy policy